Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

SELL
$187.24 - $242.74 $202,031 - $261,916
-1,079 Reduced 4.1%
25,245 $5.1 Million
Q3 2022

Oct 24, 2022

SELL
$177.23 - $227.44 $38,990 - $50,036
-220 Reduced 0.83%
26,324 $5.02 Million
Q2 2022

Jul 22, 2022

SELL
$181.58 - $368.0 $2.24 Million - $4.53 Million
-12,320 Reduced 31.7%
26,544 $4.89 Million
Q1 2022

May 02, 2022

BUY
$303.87 - $423.8 $16,408 - $22,885
54 Added 0.14%
38,864 $13.6 Million
Q4 2021

Feb 10, 2022

BUY
$347.28 - $421.83 $372,284 - $452,201
1,072 Added 2.84%
38,810 $14.8 Million
Q3 2021

Nov 03, 2021

SELL
$405.61 - $524.84 $405 - $524
-1 Reduced -0.0%
37,738 $15.3 Million
Q2 2021

Jul 30, 2021

BUY
$372.84 - $481.5 $278,138 - $359,199
746 Added 2.02%
37,739 $17.9 Million
Q1 2021

May 13, 2021

BUY
$361.28 - $504.76 $410,775 - $573,912
1,137 Added 3.17%
36,993 $14.2 Million
Q4 2020

Feb 12, 2021

BUY
$292.7 - $370.96 $4.52 Million - $5.73 Million
15,444 Added 75.66%
35,856 $13.3 Million
Q3 2020

Nov 06, 2020

BUY
$268.51 - $400.74 $536,751 - $801,079
1,999 Added 10.86%
20,412 $6.31 Million
Q2 2020

Aug 03, 2020

SELL
$256.46 - $373.01 $1.64 Million - $2.38 Million
-6,391 Reduced 25.77%
18,413 $6.82 Million
Q1 2020

May 14, 2020

BUY
$209.2 - $335.53 $387,229 - $621,066
1,851 Added 8.06%
24,804 $6.77 Million
Q4 2019

Feb 10, 2020

SELL
$288.29 - $335.49 $629,048 - $732,039
-2,182 Reduced 8.68%
22,953 $7.61 Million
Q3 2019

Nov 12, 2019

BUY
$266.84 - $378.23 $1.8 Million - $2.55 Million
6,737 Added 36.62%
25,135 $7.65 Million
Q2 2019

Aug 07, 2019

BUY
$300.59 - $368.15 $5.53 Million - $6.77 Million
18,398 New
18,398 $6.77 Million

Others Institutions Holding ILMN

About ILLUMINA, INC.


  • Ticker ILMN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 157,300,000
  • Market Cap $21.9B
  • Description
  • Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....
More about ILMN
Track This Portfolio

Track Granite Investment Partners, LLC Portfolio

Follow Granite Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Investment Partners, LLC with notifications on news.